Yi-Wen Lin Selected Research

Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)

5/2019	Short-term auricular electrical stimulation rapidly elevated cortical blood flow and promoted the expression of nicotinic acetylcholine receptor α4 in the 2 vessel occlusion rats model.
9/2010	Electroacupuncture at Baihui acupoint (GV20) reverses behavior deficit and long-term potentiation through N-methyl-d-aspartate and transient receptor potential vanilloid subtype 1 receptors in middle cerebral artery occlusion rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Wen Lin Research Topics

Disease

39	Pain (Aches) 03/2024 - 11/2011
23	Inflammation (Inflammations) 04/2024 - 12/2006
21	Hyperalgesia 02/2024 - 01/2009
20	Neoplasms (Cancer) 05/2023 - 11/2003
17	Fibromyalgia (Fibrositis) 03/2024 - 01/2015
9	Chronic Pain 07/2023 - 01/2015
7	Atherosclerosis 05/2021 - 12/2006
6	Neuralgia (Stump Neuralgia) 02/2024 - 01/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2015
5	Neuroinflammatory Diseases 07/2023 - 10/2020
5	Parkinson Disease (Parkinson's Disease) 02/2022 - 04/2017
5	Infections 10/2021 - 01/2012
4	Wounds and Injuries (Trauma) 04/2024 - 01/2019
4	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 05/2021
4	Mitochondrial Diseases (Mitochondrial Disease) 07/2023 - 03/2020
4	Neoplasm Metastasis (Metastasis) 05/2021 - 08/2010
4	Seizures (Absence Seizure) 01/2018 - 05/2011
4	Ischemia 01/2017 - 06/2014
4	Epilepsy (Aura) 01/2017 - 01/2012
3	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 04/2016
3	Cerebral Infarction 01/2017 - 01/2012
3	Breast Neoplasms (Breast Cancer) 12/2005 - 09/2004
2	Dyskinesias (Dyskinesia) 07/2023 - 06/2021
2	Tardive Dyskinesia 07/2023 - 06/2021
2	Renal Insufficiency (Renal Failure) 05/2022 - 10/2021
2	Parkinsonian Disorders (Parkinsonism) 02/2022 - 03/2020
2	Dementia (Dementias) 11/2021 - 10/2021
2	Dyslipidemias (Dyslipidemia) 05/2021 - 01/2019
2	Sarcopenia 04/2021 - 03/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 02/2017
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2019 - 09/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 12/2005
2	Brain Ischemia (Cerebral Ischemia) 11/2018 - 01/2016
2	Infarction (Infarctions) 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

13	Freund's AdjuvantIBA 01/2022 - 01/2009
10	Therapeutic UsesIBA 02/2024 - 06/2005
10	salicylhydroxamic acid (SHAM)IBA 02/2024 - 12/2015
7	Toll-Like Receptor 4IBA 02/2024 - 12/2006
7	AntioxidantsIBA 07/2023 - 09/2020
7	Analgesics (Analgesic Drugs)IBA 01/2023 - 01/2012
7	AcidsIBA 05/2021 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 07/2020 - 09/2008
5	CytokinesIBA 02/2024 - 01/2014
5	Neuroprotective AgentsIBA 07/2023 - 01/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2003
5	Kainic Acid (Kainate)IBA 01/2018 - 05/2011
4	Ion Channels (Ion Channel)IBA 06/2021 - 01/2009
4	CarrageenanIBA 01/2013 - 01/2009
3	CollagenIBA 04/2024 - 10/2017
3	Durapatite (Hydroxylapatite)IBA 10/2023 - 03/2021
3	MicroRNAs (MicroRNA)IBA 05/2023 - 01/2019
3	TeaIBA 04/2022 - 09/2020
3	theanineIBA 04/2022 - 09/2020
3	Amino Acids FDA Link 04/2022 - 09/2020
3	Neurotransmitter Agents (Neurotransmitter)IBA 06/2021 - 01/2019
3	Acid Sensing Ion ChannelsIBA 01/2020 - 01/2009
3	Transient Receptor Potential ChannelsIBA 01/2020 - 07/2010
3	Adenosine (Adenocard)FDA LinkGeneric 11/2017 - 01/2017
3	Opioid Analgesics (Opioids)IBA 11/2017 - 01/2017
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2017 - 11/2003
3	indoleIBA 02/2017 - 04/2016
2	GelatinIBA 04/2024 - 01/2021
2	Haloperidol (Haldol)FDA LinkGeneric 07/2023 - 06/2021
2	Interleukin-8 (Interleukin 8)IBA 04/2023 - 01/2014
2	InterleukinsIBA 01/2023 - 01/2014
2	HydrogelsIBA 04/2022 - 01/2021
2	CurcuminIBA 04/2022 - 04/2021
2	Interleukin-6 (Interleukin 6)IBA 04/2022 - 11/2021
2	Caspase 3 (Caspase-3)IBA 04/2022 - 08/2010
2	RotenoneIBA 02/2022 - 03/2020
2	erucylphosphocholineIBA 12/2021 - 01/2015
2	Peptides (Polypeptides)IBA 11/2021 - 01/2011
2	Polysaccharides (Glycans)IBA 11/2021 - 03/2021
2	Amyloid (Amyloid Fibrils)IBA 11/2021 - 05/2021
2	HDL LipoproteinsIBA 05/2021 - 01/2019
2	LipopolysaccharidesIBA 03/2021 - 12/2006
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2012
2	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 01/2015
2	N-Methylaspartate (NMDA)IBA 01/2020 - 09/2010
2	Toll-Like Receptor 2IBA 12/2019 - 01/2016
2	ChemokinesIBA 12/2019 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 04/2018 - 01/2015
2	N(6)-cyclopentyladenosineIBA 11/2017 - 01/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2017 - 03/2017
2	trioctyl phosphine oxide (TOPO)IBA 02/2017 - 11/2003

Therapy/Procedure

41	Electroacupuncture 02/2024 - 09/2010
20	Acupuncture Points (Acupuncture Point) 01/2024 - 09/2010
15	Therapeutics 05/2022 - 08/2010
8	Analgesia 02/2024 - 01/2012
8	Injections 09/2020 - 01/2015
4	Intravenous Injections 01/2016 - 09/2004
3	Transplantation 05/2022 - 11/2019
3	Drug Therapy (Chemotherapy) 01/2017 - 01/2016
2	Anesthesia 04/2024 - 09/2011
2	Catgut 01/2024 - 07/2023
2	Sutures (Suture) 05/2019 - 01/2014